Commentary · 2 Dec 2025
Review articlePublished 20 Dec 2014
Impact of Symptomatic HIV- Related Neurocognitive Disorders in Survival of HIV- Infected Individuals: A Systematic Review and Meta-Analyses
Public Health and Diagnostic Institute, College of Medical Sciences, Northwest University, Kano, Nigeria; Infectious and Tropical Diseases Unit, Department of Medicine, Aminu Kano Teaching Hospita/Bayero University Kano, Kano, Nigeria; Neurology Unit, Department of Medicine, Aminu Kano Teaching Hospital/ Bayero University Kano, Kano, Nigeria; Department of Medicine University of Abuja Teaching Hospital, Gwagwalada Abuja, Nigeria; Department of Medicine, Aminu Kano Teaching Hospital/ Bayero University Kano, Kano, Nigeria
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: HIV- related symptomatic neurocognitive disorders (SNCD) negatively influence the survival of affected patients. We conducted this meta-analysis to provide pooled estimates of mortality risk attributable to SNCD. Methods: MEDLINE, Google scholar, Cochrane library PsycINFO and EMBASE were the data bases thoroughly searched up to April 2014. Two parallel meta-analyses were performed to derive hazard ratio (HR) and relative risk (RR) of mortality from 7 and 6 studies respectively. The level statistical heterogeneity in the included studies was assessed using I-squared (I2) statistic while metaregression and subgroup analyses mainly explored clinical and methodological heterogeneity. Other assessments were analyses for publication bias, small study effect, single study effect and study quality. Results: Thirteen studies with satisfactory quality met the inclusion criteria. A total of 84 421 HIV+ individuals across 21 countries from Europe and America were involved. Subjects with SNCD have more than twice risk of death compared to subjects without SNCD: HR=2.1, 95% confidence interval (CI)=1.52-2.58; RR=2.46, 95% CI=1.63-3.69. The estimated HR translates in to 72% probability of subjects with SNCD dying earlier than subjects without SNCD. Risk of mortality is associated with declining CD4 cell count (p=0.038) and neurocognitive impairment in psychomotor and memory domains. In subgroup analyses, there was no significant difference in mortality risk with respect to HAART utilization, type of SNCD and availability of demographically adjusted normative scores. Despite limiting generalizability of findings to sub-Saharan Africa, inclusion of studies conducted in developed countries reduces confounding and increases the accuracy of defining pooled estimates. Conclusion: HIV- related SNCD negatively influence survival in affected patients. Routine care of these patients should include neurocognitive screening preferably with a battery assessing domains that are predictive of mortality such as psychomotor and memory domains.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Neuroinfectious Diseases.
Commentary · 1 Dec 2025
Central Nervous System Opportunistic Infections: Diagnosis and Management
Opinion · 1 Dec 2025
Cerebrospinal Fluid Biomarkers For Neurological Disease Diagnosis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Neuroinfectious Diseases
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Ahmad M Yakasai”
- BylineArticles whose byline prints “Hamza Muhammad”
- BylineArticles whose byline prints “Aliyu Ibrahim”
- BylineArticles whose byline prints “Lukman F Owolabi”
- BylineArticles whose byline prints “Mahmood M Dalhat”
- BylineArticles whose byline prints “Zaiyad G. Habib”
- BylineArticles whose byline prints “Naseer A. Ishaq”
- BylineArticles whose byline prints “Aisha M. Nalado”